BPIFA2 as a Novel Early Biomarker to Identify Fatal Radiation Injury After Radiation Exposure.
Lexin HeShixiang ZhouWeihong LiQi WangZhenhua QiPingkun ZhouZhi-Dong WangJing ChenYaqiong LiZhongwu LinPublished in: Dose-response : a publication of International Hormesis Society (2022)
The increase of serum BPIFA2 is a novel early biomarker not only for identifying radiation exposure, but also for fatal radiation injury playing a vital role in rational use of medical resources, and greater efficiency of medical treatment to minimize casualties.
Keyphrases